Study: Androgen-deprivation therapy raises risk for heart disease

10/10/2007 | Washington Post, The

A U.S. study found that prostate cancer patients who underwent androgen-deprivation therapy and prostate removal surgery are more likely to die from heart disease within five years compared to patients who only had the surgery. Researchers said a decline in testosterone levels, which suggests the efficacy of ADT in inhibiting prostate cancer, could lead to metabolic syndrome that is related to cardiac complications.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations